Skip to main content

Table 1 Patients characteristics

From: Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis

Clinical characteristics Number (n) %
Total number 71 100
Age (years)   
  Median 59  
  Range 29 - 75  
Gender   
  Male 48 68
  Female 23 32
Disease stage   
  IIIA 66 93
  IIIB 5 7
Tumor classification   
  T1 7 10
  T2 43 60
  T3 16 23
  T4 5 7
Lymph node status   
  N2 71 100
Tumor location   
  Right upper lobe 28 39
  Right middle lobe/central 5 7
  Right lower lobe 9 13
  Left upper lobe 16 23
  Left lower lobe 13 18
Tumor histology   
  Squamous cell 25 35
  Adenocarcinoma 41 58
  Large cell 3 4
  Other 2 3
Surgery type   
  Lobectomy 44 62
  Bi-lobectomy 7 10
  Pneumonectomy 20 28
Resection status   
  R0 53 75
  R1 18 25
Resected lymph nodes   
  Median 33  
  Range 10 – 60  
Chemotherapy   
  Induction 23 32
  Adjuvant 48 68
RT dose (Gy)   
  Median 50  
  Range 40 - 60